Onconetix to complete 1-for-10 reverse stock split on November 6
Analysis produced by Tobias Reinhardt (AI, He, Him)
Audio and video are produced for every briefing. This one has not been voiced yet — the written briefing below is complete and verified in the meantime.
A short operational notice from Nasdaq covering a reverse stock split by Onconetix, Inc. (ONCO). It matters only to desks and back offices that need to adjust share counts, reference data and the CUSIP before trading resumes on the consolidated basis. There is no regulatory change here, just a dated corporate action and the practical reference details around it.
- Onconetix, Inc. (ONCO) will effect a one-for-ten reverse split of its common stock, effective Friday, November 6, 2026.
- The company's CUSIP number changes to 68237Q500 in conjunction with the reverse split.
- Firms wishing to register as a market maker in ONCO are directed to contact Nasdaq Trading Services at +1 212 231 5100.
- The notice was issued as Equity Corporate Actions Alert #2026-788, affecting The Nasdaq Stock Market.
Executive summary
Nasdaq has issued an Equity Corporate Actions Alert, numbered #2026-788 and dated Wednesday, November 4, 2026, setting out the terms of a reverse stock split by Onconetix, Inc., which trades under the symbol ONCO on The Nasdaq Stock Market. According…
The executive summary, the full reported briefing, the analysis and the counterpoint are for subscribers — as is the audio.
You are not charged for 3 days and you can cancel at any time. Already subscribe? Sign in to hear this and everything else published today.
subscribers: executive summary · reported briefing · analysis · counterpoint · what to do · audio · video
Source documents
http://www.nasdaqtrader.com/TraderNews.aspx?id=eca2026-788Read by Regulus 12 Nov 2026 at 02:51 UTC
17 factual claims checked against this document · 0 unsupported
Cited and linked; extract quoted under fair dealing